Skip to main content

Your search for “Transplant” returned 230 results

Robotic Surgery with One Small Incision, U.S. First

December 22, 2011

On Tuesday, December 20th, Santiago Horgan, MD, chief of minimally invasive surgery at UC San Diego Health System was the first surgeon in the United States to remove a diseased gallbladder through a patient’s belly button with the aid of a new FDA-approved da Vinci Si Surgical System.

New Test Spots Early Signs of Inherited Metabolic Disorders

January 9, 2012

A team of scientists, led by researchers at the University of California, San Diego School of Medicine and Zacharon Pharmaceuticals, have developed a simple, reliable test for identifying biomarkers for mucopolysaccharidoses (MPS), a group of inherited metabolic disorders that are currently diagnosed in patients only after symptoms have become serious…

New Method Makes Culture of Complex Tissue Possible in any Lab

February 9, 2012

Scientists at the University of California, San Diego have developed a new method for making scaffolds for culturing tissue in three-dimensional arrangements that mimic those in the body. This advance, published online in the journal Advanced Materials, allows the production of tissue culture scaffolds containing multiple structurally and chemically distinct…

UC San Diego Orthopedic Surgeon Named New President of International Society

April 26, 2012

Steven Garfin, MD, Distinguished Professor and chair of the Department of Orthopaedic Surgery at UC San Diego Health System was named President of the International Society for the Advancement of Spine Surgery (ISASS) for 2012 to 2013.

Study Identifies Potential New Class of Drug for Treating Ulcerative Colitis

August 15, 2012

An investigational drug currently under FDA review for the treatment of rheumatoid arthritis has now shown positive results in patients with moderate-to-severe ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The study will appear in the August 16, 2012 issue of the New…

Study Finds Potential New Drug Therapy for Crohn’s Disease

October 17, 2012

Ustekinumab, an antibody proven to treat the skin condition psoriasis, has now shown positive results in decreasing the debilitating effects of Crohn’s Disease, according to researchers at the University of California San Diego, School of Medicine. The study will appear in the October 18, 2012 issue of the New England…

UC San Diego Sulpizio Cardiovascular Center Program Receives National Recognition

October 24, 2012

The physicians, surgeons and team members who pioneered the lifesaving pulmonary thromboendarterectomy (PTE) procedure at University of California, San Diego Health System are being honored for excellence at the annual CHEST conference, hosted by the American College of Chest Physicians, in Atlanta, October 20 to 25, 2012. The PTE program…

New Sports Medicine Chief Blends New Techniques with Old School Philosophy

March 4, 2013

Nationally recognized orthopedic surgeon Dr. Christopher Wahl has joined the University of California, San Diego Health System as the new chief of Sports Medicine. Recognized for his specialty in treating complex, high-energy traumatic sports injuries, Wahl will further elevate UC San Diego Health System’s reputation for offering compassionate and innovative…

Two Studies Identify Potential New Drug for Crohn’s Disease and Ulcerative Colitis

August 21, 2013

Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn’s disease and ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The findings, published in two papers, will appear in the August 22 issue of the New England Journal of…

Cancer Cells Propagated from Early Prostate Cancer

September 25, 2013

A team of cancer researchers at the University of California, San Diego has identified the existence of precursor cells in early prostate cancers. These cells are resistant to androgen-deprivation therapy, and may drive the subsequent emergence of recurrent or metastatic prostate cancer.

Category navigation with Social links